skip to Main Content

EUROQOL | News

New update of official guide to the methods of economic evaluation for France recommends use of EQ-5D-5L to derive a utility score

The French National Authority for Health (Haute Autorité de Santé or HAS) has recently published its first update of its official methodological guide for economic evaluation (Choix méthodologiques pour l'évaluation économique à la HAS). One…

Read more...

Comprehensive guide on how to analyse EQ-5D data is published

We welcome the publication of the detailed guide by Prof. Nancy Devlin, Prof. David Parkin and Dr Bas Janssen on how to analyse and report data produced by the EQ-5D. The authors have explained methods…

Read more...

EuroQol launches a new whiteboard animation, ‘Translating patient reported outcome measures for use around the world: the example of EQ-5D’

EuroQol is proud to announce the launch of a new whiteboard animation 'Translating patient reported outcome measures for use around the world: the example of EQ-5D’ , providing a step-by-step overview of how to translate…

Read more...

Study team appointed for the new UK EQ-5D-5L valuation study

The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s…

Read more...

EQ-5D is the most commonly cited multi-attribute utility instrument in review of national pharmacoeconomic guidelines

A review identifying which multi-attribute utility instruments (MAUIs) are recommended for use in official national pharmacoeconomic (PE) guidelines has been published in the European Journal of Health Economics. The study reviewed PE guidelines where health…

Read more...

First EuroQol approved sign language version of the EQ-5D-5L is now available

EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and…

Read more...

Chinese version of the EQ-5D-5L User Guide now available for download

The EuroQol Office is pleased to announce that the EQ-5D-5L User Guide is now available in Chinese (Mandarin). The User Guide provides readers with basic information on how to use the EQ-5D-5L questionnaire. Topics include…

Read more...

International valuation protocol for the EQ-5D-Y published

EuroQol is pleased to announce that, following an extensive programme of methodological research, an international evidence-based valuation protocol has been developed for the EQ-5D-Y instrument. Published in PharmacoEconomics, the new valuation protocol will enable the…

Read more...

EQ-5D licenses for COVID-19 related research

EuroQol is committed to improve decisions about health and health care throughout the world by making available EQ-5D for research on the impact of COVID-19. The EQ Office Team is handling all requests for using…

Read more...

Notice to website visitors and customers

As a result of the Covid-19 crisis the EuroQol Office team is working from home. We are doing our best to guarantee the level of service that you have become accustomed to. However, the current…

Read more...
Back To Top
Search